I-Rivaroxaban CAS 366789-02-8 Purity >99.5% (HPLC) Factory API High Quality

Incazelo emfushane:

Igama Lekhemikhali: Rivaroxaban

I-CAS: 366789-02-8

Ubumsulwa: >99.5% (HPLC)

Ukubukeka: Impushana Emhlophe noma Cishe Emhlophe

Ikhwalithi ephezulu ye-API, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Umkhiqizi Okuhlobene Ne-Rivaroxaban Intermediate:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0
I-Rivaroxaban I-CAS 446292-07-5
I-5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
I-Rivaroxaban API CAS 366789-02-8

Chemical Properties:

Igama Lekhemikhali	I-Rivaroxaban
Omqondofana	(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;I-BAY 59-7939
Inombolo ye-CAS	366789-02-8
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C19H18ClN3O5S
Isisindo samangqamuzana	435.88
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Emhlophe noma Ecishe Emhlophe
Ukuhlonza A	Ukumuncwa kwe-infrared kwe-Rivaroxaban kuhambisana namazinga okubhekisela
Ukuhlonza B	Isikhathi sokugcinwa sesiqongo esiyinhloko sesixazululo sesampula sihambisana naleso sesixazululo sokufaneleka kwesistimu, njengoba sitholwe ekuhlanzekeni kwe-enantiomeric.
I-Enantiomeric Purity	I-RVX RC01: ≤0.15%
Umswakama (KF)	≤0.50%
Umlotha one-sulphate	≤0.10%
Izinsimbi Ezisindayo	≤20ppm
I-Acetic Acid	≤5000ppm
Izinto Ezihlobene (HPLC)
I-RVX RC02	≤0.15%
I-RVX RC03	≤0.15%
I-RVX RC04	≤0.15%
I-RVX RC05	≤0.15%
I-RVX RC06	≤0.15%
I-RVX RC07	≤0.15%
I-RVX RC08	≤0.15%
Noma Ikuphi Okunye Ukungcola Komuntu Ngamunye	≤0.10%
Ukungcola Okuphelele	<0.50%
I-Residual Solvents (GC)
I-Ethanol	≤5000ppm
I-Toluene	≤890ppm
I-Triethylamine	≤320ppm
Ukuhlanzeka / Indlela Yokuhlaziya	>99.5% (HPLC) (kwisisekelo esingenamanzi)
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-API;Umuthi we-Antithrombotic;I-FXa Inhibitor

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-Rivaroxaban(I-CAS:366789-02-8) (Xarelto, Bayer) iyi-anticoagulant yomlomo.Kuyi-factor Xa inhibitor esebenzayo ngomlomo.I-Rivaroxaban iboniswa 'ukwelashwa kwe-vein thrombosis ejulile kanye ne-pulmonary embolism, nokuvimbela i-thrombosis ejulile ye-vein thrombosis kanye ne-pulmonary embolism kubantu abadala'.Ekwelapheni kokuqala kwe-acute pulmonary embolism, umthamo onconyiwe we-rivaroxaban ngu-15 mg kabili ngosuku ngezinsuku zokuqala ezingama-21 olandelwa ngu-20 mg kanye ngosuku ukuze uqhubeke nokwelashwa nokuvimbela i-thromboembolism ye-venous ephindaphindayo.I-Non-Valvular Atrial Fibrillation (i-NVAF) ukuvimbela isifo sohlangothi kanye ne-systemic embolism.Ukwelashwa okunamandla kwe-VTE nokuvimbela i-VTE ephindaphindiwe [ye-deep vein thrombosis (DVT) kanye ne-pulmonary embolism (PE)].Ukuvinjelwa kwemicimbi ye-venous thromboembolic (VTE) ekuhlinzeni okukhethiwe kwe-hip noma ukubuyisela amadolo (THR, TKR).